A 54-Year-Old Woman with Progressive Headache and Neurologic Decline
Neurol 102:e209190, Cheng,Y. & Zachariah,J., 2024
Hemophagocytic Lymphohistiocytosis Associated with the Use of Lamotrigine
Neurol 92:e2401-e2405, Kim, T.,et al, 2019
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009
Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007
Transient Lesion in the Splenium of the Corpus Callosum and Antiepileptic Drug Withdrawal
Neurol 65:1032-1036, Gurtler,S.,et al, 2005
Transient Lesion in the Splenium of the Corpus Callosum in an Epileptic Patient
Neurol 60:1838-1841, Mirsattari,S.M.,et al, 2003
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Visual Function Loss From Vigabatrin
Neurol 55:40-45, Johnson,M.A. et al, 2000
Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999
Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999
Vigabatrin, a Gabaergic Antiepileptic Drug, Causes Concentric Visual Field Defects
Neurol 53:922-926, Kalviainen,R.,et al, 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
Lamotrigine-Associated Anticonvulsant Hypersentivitiy Syndrome
Neurol 51:1171-1175, Schlienger,R.G.,et al, 1998
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Severe Persistent Visual Field Constriction Associated with Vigabatrin
BMJ 14:180-181, Eke,T.,et al, 1997
Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
Epilepsy
JNNP 57:264-277, Chadwick,D., 1994
Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994
Prolonged Absence Status epilepticus Assoc with Carbamazepine, Increased ICP & Trans MRI Abnor
Neurol 42:2198-2201, Callahan,D.J.&Noetzel,M.J., 1992
Valproic Acid-Induced Cytopenias:Evidence for a Dose-Related Suppression of Hematopoiesis
J Pediatr 117:495-497, Watts,R.G.,et al, 1990
Hypersensitivity to Carbamazepine Presenting with a Leukemoid Reaction, Eosinophilia, Erythroderma, and Renal Failure
Neurol 39:436-438, Ray-Chaudhuri,K.,et al, 1989
New-Onset Seizures Associated with Human Immunodeficiency Virus Infection: Causation and Clinical Features in 100 Cases
Am J Med 87:173-177, Holtzman, D.M.,et al, 1989
Sodium Valproate
Editorial, Lancet 2:1229-12311988., , 1988
Carbamazepine & Hematological Monitoring
Ann Neurol 11:309-312, Hart,R.G.,et al, 1982
Sodium Valproate & Bone Marrow Suppression
Ann Neurol 8:197-199, Smith,F.R.,et al, 1980
Thrombocytopenia Associated with Sodium Valproate Treatment
Ann Neurol 5:389-390, Neophytides,A.N.,et al, 1979
Phenytoin Hypersensitivity:38 Cases
Neurol 29:1480-1485, Harunda,F., 1979
Late-Onset Thrombocytopenia with Phenytoin Therapy
Ann Neurol 6:370, Fincham,R.W.,et al, 1979
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979